{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:54:38Z","timestamp":1792814078631,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jcrs.2008.03.017","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T08:43:33Z","timestamp":1213865013000},"page":"1114-1120","source":"Crossref","is-referenced-by-count":87,"title":["Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery"],"prefix":"10.1097","volume":"34","author":[{"given":"Lisa Brothers","family":"Arbisser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group.","volume":"32","author":"Barry","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R2-25-20210210","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.","volume":"33","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R3-25-20210210","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0886-3350(01)01269-X","article-title":"Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R4-25-20210210","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0886-3350(01)01270-6","article-title":"Zetterstrom. Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R5-25-20210210","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcrs.2006.02.014","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group.","volume":"32","author":"Seal","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R6-25-20210210","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0161-6420(98)96000-6","article-title":"Nosocomial acute-onset postoperative endophthalmitis survey: a ten-year review of incidence and outcomes.","volume":"105","author":"Aaberg","year":"1998","journal-title":"Ophthalmology"},{"key":"R7-25-20210210","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jcrs.2005.01.031","article-title":"Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997-2001).","volume":"31","author":"Khan","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"R8-25-20210210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archopht.123.5.613","article-title":"Acute endophthalmitis following cataract surgery; a systematic review of the literature.","volume":"123","author":"Taban","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R9-25-20210210","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2005.02.028","article-title":"The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001.","volume":"112","author":"West","year":"2005","journal-title":"Ophthalmology"},{"key":"R11-25-20210210","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"Results of the endophthalmitis vitrectomy study; a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis.","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R12-25-20210210","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine.","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"R13-25-20210210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","article-title":"Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update.","volume":"109","author":"Ciulla","year":"2002","journal-title":"Ophthalmology"},{"key":"R16-25-20210210","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0886-3350(97)80081-8","article-title":"Anterior chamber contamination during cataract surgery with intraocular lens implantation.","volume":"23","author":"Mistlberger","year":"1997","journal-title":"J Cataract Refract Surg"},{"key":"R17-25-20210210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9394(14)76728-5","article-title":"Anterior chamber aspirate cultures after uncomplicated cataract surgery.","volume":"112","author":"Dickey","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R19-25-20210210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.eye.6701899","article-title":"Influence of age on conjunctival bacteria of patients undergoing cataract surgery.","volume":"20","author":"Rubio","year":"2006","journal-title":"Eye"},{"key":"R20-25-20210210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jcrs.2006.01.067","article-title":"Vigamox: how good is its self-preservation?","volume":"32","author":"Haas","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R21-25-20210210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0002-9394(74)90016-6","article-title":"Cytotoxicity of ophthalmic preservatives.","volume":"78","author":"Gasset","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"R22-25-20210210","first-page":"395","article-title":"Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro.","volume":"6","author":"Tripathi","year":"1989","journal-title":"Lens Eye Toxic Res"},{"issue":"suppl","key":"R23-25-20210210","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.survophthal.2005.06.002","article-title":"In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5; a new topical fluoroquinolone.","volume":"50","author":"Stroman","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R24-25-20210210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R25-25-20210210","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2005.06.025","article-title":"An ophthalmologists guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.","volume":"112","author":"Kowalski","year":"2005","journal-title":"Ophthalmology"},{"key":"R26-25-20210210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"suppl 1","key":"R27-25-20210210","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.survophthal.2005.05.003","article-title":"Safety of moxifloxacin as shown in animal and in vitro studies.","volume":"50","author":"McGee","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R28-25-20210210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.ico.0000170689.75207.5e","article-title":"Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.","volume":"25","author":"Kleinmann","year":"2006","journal-title":"Cornea"},{"key":"R29-25-20210210","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/01.ico.0000220777.70981.46","article-title":"Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.","volume":"25","author":"Ritterband","year":"2006","journal-title":"Cornea"},{"key":"R31-25-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/02713680601160610","article-title":"Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography.","volume":"32","author":"Perente","year":"2007","journal-title":"Curr Eye Res"},{"key":"R32-25-20210210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.eye.6701864","article-title":"Cystoid macular oedema and changes in retinal thickness after phacoemulsification with optical coherence tomography.","volume":"20","author":"Ching","year":"2006","journal-title":"Eye"},{"key":"R33-25-20210210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajo.2005.04.015","article-title":"Intracameral Vigamox (moxifloxacin 0.5) is non-toxic and effective in preventing endophthalmitis in a rabbit model.","volume":"140","author":"Kowalski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R34-25-20210210","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.ophtha.2005.06.017","article-title":"Aqueous penetration and biological activity of moxifloxacin 0.5 ophthalmic solution and gatifloxacin 0.3 solution in cataract surgery patients.","volume":"112","author":"Kim","year":"2005","journal-title":"Ophthalmology"},{"key":"R35-25-20210210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5 ophthalmic solution in cataract surgery patients.","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R36-25-20210210","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jcrs.2007.06.026","article-title":"Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.","volume":"33","author":"OBrien","year":"2007","journal-title":"J Cataract Refract Surg"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335008003337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335008003337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2008.03.017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T16:42:04Z","timestamp":1620924124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02158034-200807000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2008.03.017","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}